Article
Original and generic clopidogrel: A comparison of antiplatelet effects and active metabolite concentrations in patients without polymorphisms in the ABCB1 gene and the allele variants CYPC19*2 and *3.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 May 2021
Wójcik Tomasz, Szymkiewicz Paweł, Ściborski Krzysztof, Łukaszewski Marceli, Onisk Grzegorz, Mysiak Andrzej, Gamian Andrzej, Wiśniewski Jerzy, Dobosz Tadeusz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marcin
Abstract excerpt
BACKGROUND: Ticagrelor and prasugrel are widely used as antiplatelet therapy after coronary angioplasty. However, there is a group of patients with indications for clopidogrel treatment. This population includes patients with chronic or acute coronary syndrome who are treated invasively and have contraindications to the use of novel antiplatelet drugs due to antithrombotic treatment (particularly with non-vitamin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.